Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-043439
Filing Date
2022-04-07
Accepted
2022-04-07 08:09:44
Documents
3
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2210624-1_def14a.htm DEF 14A 525760
2 GRAPHIC tm2210624d1-px_01proxybw.jpg GRAPHIC 360254
3 GRAPHIC tm2210624d1-px_02proxy4c.jpg GRAPHIC 219849
  Complete submission text file 0001104659-22-043439.txt   1306454
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-38247 | Film No.: 22812348
SIC: 2834 Pharmaceutical Preparations